Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP692974.RAaElMibe6L1XGsKB4aa6UbltlMIrcvAWLXe3I2JBc9M8130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692974.RAaElMibe6L1XGsKB4aa6UbltlMIrcvAWLXe3I2JBc9M8130_provenance.
• NP617714.RAU59m-mkpK7ziOg79oP0WRlS4zHTUWt16lVkdQivGCNo130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617714.RAU59m-mkpK7ziOg79oP0WRlS4zHTUWt16lVkdQivGCNo130_provenance.
• NP939961.RA7ipBU7TRWBHjYzajxaddTrTEMySfLDiTzuN_cxN87LA130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939961.RA7ipBU7TRWBHjYzajxaddTrTEMySfLDiTzuN_cxN87LA130_provenance.
• NP232218.RAy_iufa5bXmxeAl9A3GKhYZ8g4fYYuFYpZKZO1X1d5uw130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232218.RAy_iufa5bXmxeAl9A3GKhYZ8g4fYYuFYpZKZO1X1d5uw130_provenance.
• NP644258.RAWny5wFZZAzy9u7fMrEjLPfyF5Xbm030ftbqi1ZFjAlU130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644258.RAWny5wFZZAzy9u7fMrEjLPfyF5Xbm030ftbqi1ZFjAlU130_provenance.
• NP768267.RAyqskW04zX9vg6DRUgyHS7J-5mBo68O9OChcQvhOB6CU130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768267.RAyqskW04zX9vg6DRUgyHS7J-5mBo68O9OChcQvhOB6CU130_provenance.
• NP768269.RAIETlGQb0CiptMBScibYndlKNifPbvk4XjmXET59F5To130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768269.RAIETlGQb0CiptMBScibYndlKNifPbvk4XjmXET59F5To130_provenance.
• NP768271.RAH6KAlHP5U7EeDox5b5EP0YsJ8MWGDsQMLrftpap9h-4130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768271.RAH6KAlHP5U7EeDox5b5EP0YsJ8MWGDsQMLrftpap9h-4130_provenance.
• NP376672.RAqJO-G0e-JXCGAtTSXS9E3eTX_ImvLN8YKqV_5Kll6rA130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376672.RAqJO-G0e-JXCGAtTSXS9E3eTX_ImvLN8YKqV_5Kll6rA130_provenance.
• NP768266.RAiS3GJHFUjZdlUNJ5h-SibFgPMtWmMu8aF_1VwB-DVE8130_assertion description "[Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768266.RAiS3GJHFUjZdlUNJ5h-SibFgPMtWmMu8aF_1VwB-DVE8130_provenance.